Myeloma
Studies from University of Arkansas have provided new data on myeloma
Published in Cancer Weekly, December 30th, 2008
"Killer immunoglobulin-like receptor (KIR)-ligand mismatched natural killer (NK) cells play a key role in achieving durable remission after haplo-identical transplantation for acute myeloid leukaemia. We investigated the feasibility of transfusing haplo-identical, T-cell depleted, KIR-ligand mismatched NK cells, after conditioning therapy with melphalan and fludarabine, to patients with advanced multiple myeloma (MM) followed by delayed rescue with autologous stem cells," scientists writing in the British Journal of Haematology report.
"No graft-versus-host disease or failure of autologous stem cells to engraft was observed. There was significant variation in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-12-30)
More Articles from Cancer Weekly
- University Hospital Heidelberg
Protection from the own immune system - Wiley-Blackwell
USA's largest ever prostate cancer screening program shows high compliance and consistent results - Cancer
MyCancerPain.org Launched as Resource for Patients with Painful Bone Metastases - Cancer Gene Therapy
New cancer gene therapy research from University of Pittsburgh outlined - Cancer Gene Therapy
New cancer gene therapy research has been reported by M. Loeffler et al - Cancer Gene Therapy
Reports from University of Strasbourg advance knowledge in cancer gene therapy - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
